ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 197 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $111,455,000 | +0.9% | 8,959,423 | +11.0% | 0.02% | -8.7% |
Q3 2016 | $110,484,000 | +90.9% | 8,070,403 | +3.0% | 0.02% | +76.9% |
Q2 2016 | $57,879,000 | +14.9% | 7,832,019 | -0.6% | 0.01% | +8.3% |
Q1 2016 | $50,359,000 | +0.8% | 7,880,858 | -1.4% | 0.01% | 0.0% |
Q4 2015 | $49,979,000 | +4.0% | 7,996,641 | -2.8% | 0.01% | 0.0% |
Q3 2015 | $48,056,000 | -29.8% | 8,228,791 | -0.6% | 0.01% | -25.0% |
Q2 2015 | $68,470,000 | -0.6% | 8,279,306 | -1.0% | 0.02% | 0.0% |
Q1 2015 | $68,911,000 | +26.2% | 8,363,038 | +5.2% | 0.02% | +23.1% |
Q4 2014 | $54,589,000 | +38.9% | 7,945,954 | +9.2% | 0.01% | +18.2% |
Q3 2014 | $39,295,000 | -4.2% | 7,276,922 | +13.0% | 0.01% | -8.3% |
Q2 2014 | $41,021,000 | +41.1% | 6,439,785 | +78.5% | 0.01% | +33.3% |
Q1 2014 | $29,074,000 | +18.2% | 3,607,176 | 0.0% | 0.01% | +28.6% |
Q4 2013 | $24,601,000 | -64.2% | 3,607,176 | -3.3% | 0.01% | -69.6% |
Q3 2013 | $68,644,000 | +15.6% | 3,730,636 | +9.9% | 0.02% | +4.5% |
Q2 2013 | $59,393,000 | – | 3,395,820 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
Geduld E E | 185,100 | $1,157,000 | 0.72% |
Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |